Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine

Journal of Physiology and Pharmacology

Volumn 56, Issue 2, 2005, Pages 325-333

  Nowak, Przemysław ^a   Kostrzewa, R M ^b   Kwiecinski A ^a   Bortel, A ^a   Labus, L ^a   Brus, R ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b East Tennessee State University   (United States)

Author keywords

6 hydroxydopamine (6 OHDA); Behavioral sensitization; D amphetamine; Dopamine; Lesion; Rats

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; HOMOVANILLIC ACID; KETAMINE; OXIDOPAMINE; PARGYLINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; METABOLITE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; RAT; SENSITIZATION;

ANIMALS; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; MALE; MOTOR ACTIVITY; OXIDOPAMINE; RATS; RATS, WISTAR; SUBSTANTIA NIGRA;

EID: 21344437525     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Keitz M, Martin-Soelch C, Leenders KL. Reward processing in the brain: a prerequisite for movement preparation? Neural Plast 2003; 10: 121-128.
2. Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J. Neurosci 2002; 22: 4654-4662.
3. Brus R, Szkilnik R, Nowak P, Kasperska A, Oświȩcimska J, Kostrzewa RM, et al. Locomotor sensitization of dopamine receptors by their agonists quinpirole and SKF 38393, during maturation and aging in rats. Pharmacol Rev Commun 1998; 10: 25-30.
4. Louk J, Vanderschuren MJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 200; 151: 99-120.
5. Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000; 151: 99-120.
6. Itzhak Y, Martin JL. Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: cocaine-alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites. Brain Res 1999; 818: 204-211.
7. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 1993; 264: 249-255.
8. Nowak P, Brus R, Kostrzewa RM. Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol J Pharmacol 2001; 53: 319-329.
9. Paulson PE, Robinson TE. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striarum: a microdialysis study in behaving rats. Synapse 1995; 19: 56-65.
10. Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J. Neurosci 1000; 19: 9579-9586.
11. Kostrzewa RM, Kostrzewa JP, Nowak P, Kostrzewa RA, Brus R. Dopamine D2 agonist priming in intact and dopamine-lesioned rats. Neurotox Res 2004; 6: 457-462.
12. Datla KP, Murray HE, Pillai AV, Gillies GE, Dexter DT. Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle. Neuroreport 2003; 14: 47-50.
13. Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R. Peculiarities of L-DOPA treatment of Parkinson's disease. Amino Acids 2005; 28: 157-164.
14. Van Kampen JM, McGeer EG, Stoessl AJ. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity. Synapse 2000; 37: 171-178.
15. Kostrzewa RM. Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond. Neurotox Res 1999; 1: 3-25.
16. Srinivasan J, Schmidt WJ. Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion. Synapse 2004; 513: 213-218.
17. Brus R, Kostrzewa RM, Perry KW, Fuller RW. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J Pharmacol Exp Ther 1994; 268: 231-237.
18. Kostrzewa RM, Brus R, Perry KW, Fuller RW. Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Brain Res Dev Brain Res 1993; 76: 87-93.
19. Grant RJ, Clarke PB. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia. Neuroscience 2002; 115: 1281-1294.
20. Murray HE, Pillai AV, McArthur SR, Razvi N, Datla KP, Dexter DT, et al. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. Neuroscience 2003; 116: 213-222.
21. Wagner J, Vitali P, Palfreyman MG, Zraika M, Huot S. Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J Neurochem 1982; 38: 1241-1254.
22. Nowak P, Brus R, Oswiecimska J, Sokola A, Kostrzewa RM. 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. an in vivo microdialysis and voltammetric study. J Physiol Pharmacol 2002; 53: 251-263.
23. Benoit-Marand M, Jaber M, Gonon F. Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences. Eur J Neurosci 2000; 12: 2985-2992.
24. Huotari M, Garcia-Horsman JA, Karayiorgou M, Gogos JA, Mannisto PT. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice. Psychopharmacology (Berl) 2004; 172: 1-10.
25. Shilling PD, Kelsoe JR, Segal DS. Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci Lett 1997; 236: 131-134.
26. Mead AN, Rocha BA, Donovan DM, Katz JL. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice. Eur J Neurosci 2002; 16: 514-520.
27. Brown JM, Riddle EL, Sandoval V, Weston RK, Hanson JE, Crosby MJ, et al. A single methamphetamine administration rapidly decreases vesicular dopamine uptake. J Pharmacol Exp Ther 2002; 302: 497-501.
28. Lee MA, Lee HS, Cho KG, Jin BK, Sohn S, Lee YS, et al. Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins. Neurosci Lett 2002; 333: 74-78.
29. Zigmond MJ, Keefe KA. 6-Hydroxydopamine as a tool for studying catecholamines in adult animals. In: Kostrzewa, R.M. (Ed.), Highly Selective neurotoxins. Basic and Clinical Applications. Humana Press Inc., New Jersey, 1998; pp. 75-107.